Tag: AstraZeneca

AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer

AstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live 23 months longer than those who received just chemoradiotherapy, according to clinical trial data released Sunday. The finding should help the U.K.-based pharmaceutical company expand the drug’s use in the disease. Researchers in the study, called Adriatic, used Imfinzi […]

Pfizer wins cancer drug patent case against AstraZeneca

The US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer in damages for infringing patents related to the lung cancer drug Tagrisso. The patents in question are licensed by Pfizer to Puma Biotechnology for the production of the breast cancer drug Nerlynx, Reuters has reported. The jury found […]

AstraZeneca to withdraw COVID vaccine globally as demand dips

(Reuters) -AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic. The company also said it would proceed to withdraw the vaccine Vaxzevria’s marketing authorizations within Europe. “As multiple, variant COVID-19 vaccines have since been developed there is a surplus […]

AstraZeneca withdraws its COVID-19 vaccine from global market

AstraZeneca is withdrawing its COVID-19 vaccine from the market because of low demand, the drugmaker said Wednesday. The shot, which was never authorized in the U.S., was widely used across the world in the early part of the global vaccine drive. AstraZeneca’s shot was cheaper to make and easier to distribute than the mRNA shots […]

AstraZeneca withdraws Covid jab from market due to plummeting demand

The Covid-19 vaccine developed by pharmaceutical giant AstraZeneca during the pandemic has been withdrawn from the market. The company said it was “incredibly proud” of the vaccine, but that it had been withdrawn due to plummeting demand. Vaccine makers agreed that it could be manufactured on a “not-for-profit basis for the duration of the pandemic […]

AstraZeneca withdraws Covid vaccine as demand dives

Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing “commercial reasons” following a slump in demand. “As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines. This has led to a decline in demand for […]

AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies

AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Gracell Biotechnologies Inc (NASDAQ: GRCL), further strengthening AstraZeneca’s cell therapy portfolio. The deal value is $2.00/share (equivalent to $10/ADS ADS of Gracell) plus a non-tradable contingent value right of $0.30/share (equivalent to $1.50/ADS of Gracell) in cash. The proposed acquisition will enrich AstraZeneca’s growing pipeline of cell therapies with GC012F, a […]